N.Y. EDN Law § 6811-C

This is the official text of N.Y. EDN Law § 6811-C, part of New York’s EDN Law — part of the compiled statutory law of New York, published by the state as "EDN Law." Browse the sections below, each linked to its official government source.

Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.

Patient notification of recalled drugs

Official statutory text

§ 6811-c. Patient notification of recalled drugs. 1. For purposes of\nthis section the term "class I recall" shall mean a situation in which\nthe United States food and drug administration deems there is reasonable\nprobability that the use of or exposure to a violative product will\ncause serious adverse health consequences or death.\n 2. Where there has been a class I recall of a prescription drug,\npharmacies shall make a reasonable attempt to notify all patients that\nhave been prescribed and who are currently taking such recalled drug\ndispensed from such pharmacy by phone or by mail within three days of\nthe pharmacy being notified by the United States food and drug\nadministration, a manufacturer, a wholesaler or by other notice of such\nrecall.\n 3. The notification required by this section may be provided by an\nindividual pharmacy or by a central office in the case of a pharmacy\nthat is part of a chain.\n

Status: in_force · Read it on the official government site

Need a lawyer in New York?

Find a New York lawyer
About this page: Statute text is reproduced from official government publishers via the Open US Law dataset (Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine (Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.